RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice

Antioxidants and Redox Signaling

Volumn 21, Issue 15, 2014, Pages 2083-2094

  Han, Yong Hyun ^a   Kim, Hyeon Ji ^a   Kim, Eun Jin ^a   Kim, Kyu Seo ^a   Hong, Suckchang ^a   Park, Hyeung Geun ^a   Lee, Mi Ock ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALANINE AMINOTRANSFERASE; CHOLESTEROL SULFATE; GLUTATHIONE PEROXIDASE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; RETINOID RELATED ORPHAN RECEPTOR ALPHA; STEARIC ACID; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GLUTATHIONE PEROXIDASE; RORA PROTEIN, MOUSE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; KUPFFER CELL; LIPID PEROXIDATION; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPECTROFLUOROMETRY; SURFACE PLASMON RESONANCE; ANIMAL; C57BL MOUSE; DNA RESPONSIVE ELEMENT; ENZYME INDUCTION; GENETIC TRANSCRIPTION; GENETICS; HEPG2 CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

MUS;

ANIMALS; CYTOKINES; ENZYME INDUCTION; GLUTATHIONE PEROXIDASE; HEP G2 CELLS; HUMANS; KUPFFER CELLS; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RESPONSE ELEMENTS; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC;

EID: 84921051623     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5655     Document Type: Article

References (43)

1. Baker SS, Baker RD, Liu W, Nowak NJ, and Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS One 5: e9570, 2010.
2. Boukhtouche F, Vodjdani G, Jarvis CI, Bakouche J, Staels B, Mallet J, Mariani J, Lemaigre-Dubreuil Y, and Brugg B. Human retinoic acid receptor-related orphan receptor alpha1 overexpression protects neurones against oxidative stress-induced apoptosis. J Neurochem 96: 1778-1789, 2006.
3. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, and Rizzetto M. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123: 134-140, 2002.
4. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, and Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative realtime PCR experiments. Clin Chem 55: 611-622, 2009.
5. Caballero B, Vega-Naredo I, Sierra V, Huidobro-Fernández C, Soria-Valles C, De Gonzalo-Calvo D, Tolivia D, Gutierrez-Cuesta J, Pallas M, Camins A, Rodr?guez-Colunga MJ, and Coto-Montes A. Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice. J Pineal Res 45: 302-311, 2008.
6. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, and Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942, 2005.
7. Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, and Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54: 133-144, 2011.
8. Day CP and James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
9. Farrell GC, van Rooyen D, Gan L, and Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6: 149-171, 2012.
10. Forman HJ and Torres M. Redox signaling in macrophages. Mol Aspects Med 22: 189-216, 2001.
11. Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, Scott DK, and O'Doherty RM. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59: 347-357, 2010.
12. Ip E, Farrell G, Hall P, Robertson G, and Leclercq I. Administration of the potent PPARalpha agonist, Wy-14, 643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39: 1286-1296, 2004.
13. Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7: e003, 2009.
14. Kallen J, Schlaeppi JM, Bitsch F, Delhon I, and Fournier B. Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2 A. J Biol Chem 279: 14033-14038, 2004.
15. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I, and Fournier B. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10: 1697-1707, 2002.
16. Kang HS, Okamoto K, Takeda Y, Beak JY, Gerrish K, Bortner CD, DeGraff LM, Wada T, Xie W, and Jetten AM. Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis. Physiol Genomics 43: 818-828, 2011.
17. Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, Lee IK, and Lee MO. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol 28: 1796-1802, 2008.
18. Kim EJ, Yoon YS, Hong S, Son HY, Na TY, Lee MH, Kang HJ, Park J, Cho WJ, Kim SG, Koo SH, Park HG, and Lee MO. Retinoic acid receptor-related orphan receptor ainduced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis. Hepatology 55: 1379-1388, 2012.
19. Koek GH, Liedorp PR, and Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 412: 1297-1305, 2011.
20. Laurent A, Nicco C, Tran Van Nhieu J, Borderie D, Chéreau C, Conti F, Jaffray P, Soubrane O, Calmus Y, Weill B, and Batteux F. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 39: 1277-1285, 2004.
21. Malhi H and Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 28: 360-369, 2008.
22. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, and Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923, 2003.
23. Matés JM, Pérez-Gómez C, and Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32: 595-603, 1999.
24. Miyake T, Kumagi T, Hirooka M, Furukawa S, Koizumi M, Tokumoto Y, Ueda T, Yamamoto S, Abe M, Kitai K, Hiasa Y, Matsuura B, and Onji M. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospecitve longitudinal cohor study. J Gastroenterol 48: 413-422, 2013.
25. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
26. Na TY, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, and Lee MO. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Hepatology 49: 1122-1131, 2009.
27. Ou Z, Shi X, Gilroy RK, Kirisci L, Romkes M, Lynch C, Wang H, Xu M, Jiang M, Ren S, Gramignoli R, Strom SC, Huang M, and Xie W. Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORa and RORc and its potential relevance to human liver diseases. Mol Endocrinol 27: 106-115, 2013.
28. Park Y, Hong S, Lee M, Jung H, Cho WJ, Kim EJ, Son HY, Lee MO, and Park HG. N-methylthioureas as new agonists of retinoic acid receptor-related orphan receptor. Arch Pharm Res 35: 1393-1401, 2012.
29. Saha P and Das S. Elimination of deleterious effects of free radicals in murine skin carcinogenesis by black tea infusion, theaflavins and epigallocatechin gallate. Asian Pac J Cancer Prev 3: 225-230, 2002.
30. Singh S, Loke YK, and Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 298: 1189-1195, 2007.
31. Shah P and Mudaliar S. Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 9: 347-354, 2010.
32. Solt LA and Burris TP. Action of RORs and their ligands in (patho)physiology. Trends Endocrinol Metab 23: 619-627, 2012.
33. Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S, and Müller M. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 51: 511-522, 2010.
34. Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, and Hahn YS. Kupffer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-a production. J Biol Chem 287: 40161-40172, 2012.
35. von Montfort C, Matias N, Fernandez A, Fucho R, Conde de la Rosa L, Martinez-Chantar ML, Mato JM, Machida K, Tsukamoto H, Murphy MP, Mansouri A, Kaplowitz N, Garcia-Ruiz C, and Fernandez-Checa JC. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol 57: 852-829, 2012.
36. Wang Y, Kumar N, Nuhant P, Cameron MD, Istrate M. A, Roush WR, Griffin PR, and Burris TP. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORa and RORc. ACS Chem Biol 5: 1029-1034, 2010.
37. Wardman P. Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med 43: 995-1022, 2007.
38. Wiesenberg I, Missbach M, Kahlen JP, Schräder M, and Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 23: 327-333, 1995.
39. Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, Sung JJ, and Yu J. PPARgamma is essential for protection against nonalcoholic steatohepatitis. Gene Ther 17: 790-798, 2010.
40. Wu S, Wu Y, Wu T, and Wei Y. Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress. Biochim Biophys Acta 1840: 1331-1344, 2014.
41. Xu Y, Porntadavity S, and St Clair DK. Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem J 362: 401-412, 2002.
42. Zhan YT and An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 16: 4652-4660, 2010.
43. Zhang D, Xie L, Wei Y, Liu Y, Jia G, Zhou F, and Ji B. Development of a cell-based antioxidant activity assay using dietary fatty acid as oxidative stressor. Food Chem 141: 347-356, 2013.